George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
NDN, be surprised if shareholders (of any company) were to be advised every time an evaluation had been completed, & not even sure it's obligatory to rns. However, following the evaluation I'm sure we'll soon be advised the status of BAMS....by rns & not vox.
NDN, if that as a reply to me, please be more specific. I can be specific about what was advised & when, so wonder if it's your interpretation of what was stated rather than what was actually stated, which was:
"This evaluation is expected to continue for another two or three weeks and the Group is establishing outsourced manufacturing capacity for the BAMS tests in collaboration with Adeptrix so that it is in a position to formally validate the diagnostic product as soon as possible. Avacta is also in discussions with a large commercial partner to provide a route to market for the BAMS assay."
No promise there.
RAC is a SPAC with $137.5m cash
https://www.researchalliancecorp.com/
Goes back to their rns 23 dec in which they announced framework agreement (10 yrs) with a major global OEM for the manufacture of complex medical diagnostic disposable devices. BBI? Mologic? etc etc?
https://www.lse.co.uk/rns/CAR/framework-agreement-lbx32tubukyttum.html
Paraytec device
https://www.paraytec.com/about/covid19-test/
On investing.com the sp has just popped up again @ 5p. This has happened several times over last 24 hours. May be just an anomaly, if not anyone have a clue what's going on?